Close

Taro Pharma (TARO) Reports Q2 EPS of $3.11

November 4, 2015 7:16 AM EST

Taro Pharma (NYSE: TARO) reported Q2 EPS of $3.11, versus $3.35 reported last year. Revenue for the quarter came in at $212.1 million, versus $250.8 million reported last year.

For earnings history and earnings-related data on Taro Pharma (TARO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings